Literature DB >> 23117771

Transforming clinical trials in cardiovascular disease: mission critical for health and economic well-being.

Elliott M Antman1, Robert A Harrington.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23117771     DOI： 10.1001/jama.2012.14841

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  14 in total

1.  Challenges in Implementing Hospice Clinical Trials: Preserving Scientific Integrity While Facing Change.

Authors:  Debra Parker Oliver; Karla T Washington; George Demiris; Patrick White
Journal:  J Pain Symptom Manage       Date:  2019-10-11       Impact factor: 3.612

Review 2.  Precision medicine in cardiology.

Authors:  Elliott M Antman; Joseph Loscalzo
Journal:  Nat Rev Cardiol       Date:  2016-06-30       Impact factor: 32.419

Review 3.  Efficient design of clinical trials and epidemiological research: is it possible?

Authors:  Michael S Lauer; David Gordon; Gina Wei; Gail Pearson
Journal:  Nat Rev Cardiol       Date:  2017-04-27       Impact factor: 32.419

4.  Real-World Evidence: Promise and Peril For Medical Product Evaluation.

Authors:  Sanket S Dhruva; Joseph S Ross; Nihar R Desai
Journal:  P T       Date:  2018-08

5.  Standards for Clinical Research: Keeping Pace With the Technology of the Future.

Authors:  Elliott M Antman; Barbara E Bierer
Journal:  Circulation       Date:  2016-03-01       Impact factor: 29.690

6.  Achieving Milestones as a Prerequisite for Proceeding With a Clinical Trial.

Authors:  Angela M Mickle; Hannah R Maybrier; Anke C Winter; Sherry L McKinnon; Brian A Torres; Nan Lin; Eric J Lenze; Susan Stark; Maxwell R Muench; Eric Jacobsohn; Sharon K Inouye; Michael S Avidan; Troy S Wildes
Journal:  Anesth Analg       Date:  2018-06       Impact factor: 5.108

Review 7.  From Nonclinical Research to Clinical Trials and Patient-registries: Challenges and Opportunities in Biomedical Research.

Authors:  José M de la Torre Hernández; Elazer R Edelman
Journal:  Rev Esp Cardiol (Engl Ed)       Date:  2017-08-31

8.  Commentary on Vickers.

Authors:  Michael S Lauer
Journal:  Clin Trials       Date:  2014-12       Impact factor: 2.486

9.  The SGLT2 inhibitor canagliflozin in heart failure: the CHIEF-HF remote, patient-centered randomized trial.

Authors:  Mikhail N Kosiborod; James L Januzzi; John A Spertus; Mary C Birmingham; Michael Nassif; C V Damaraju; Antonio Abbate; Javed Butler; David E Lanfear; Ildiko Lingvay
Journal:  Nat Med       Date:  2022-02-28       Impact factor: 87.241

10.  The Mid-South clinical Data Research Network.

Authors:  S Trent Rosenbloom; Paul Harris; Jill Pulley; Melissa Basford; Jason Grant; Allison DuBuisson; Russell L Rothman
Journal:  J Am Med Inform Assoc       Date:  2014-05-12       Impact factor: 4.497
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.